Nephrology Research Review, Issue 48

In this issue:

Cardiovascular benefits of sotagliflozin in patients with diabetes and CKD
Renal benefits of dapagliflozin in patients with CKD
Dapagliflozin in patients with diabetic vs non-diabetic CKD
Finerenone treatment in patients with diabetic kidney disease
Disappointing findings for electronic health record alerts in AKI patients
Longitudinal effects of COVID-19– associated AKI on kidney function after hospital discharge
Fixed-dose vs titrated-dose darbepoetin alfa in CKD patients
Rituximab vs cyclic corticosteroid-cyclophosphamide regimen for membranous nephropathy
Treatment regimen for primary membranous nephropathy: the STARMEN trial
Use of aspirin in older adults with CKD: post hoc analysis of ASPREE

Please login below to download this issue (PDF)

Subscribe